Status:

RECRUITING

Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients

Lead Sponsor:

University Hospital, Limoges

Conditions:

Stroke

Central Nervous System Diseases

Eligibility:

All Genders

35-75 years

Phase:

NA

Brief Summary

The primary objective of this study is to evaluate the tolerance of the use of immersive virtual reality (VR) during robotic walking rehabilitation sessions by Gait Trainer (GT) in post-stroke patient...

Detailed Description

Robotic Assisted Gait Therapy using the GT has been shown to be effective in restoring gait to non-walking stroke patients. However, GaitTrainer rehabilitation sessions can result in fatigue, sling at...

Eligibility Criteria

Inclusion

  • Hemiparesis following a first ischemic or hemorrhagic stroke;
  • subacute phase (15 days to 6 months);
  • Aged 35 to 75 years;
  • Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2);
  • Benefiting from robot-assisted walking rehabilitation in the readaptation and physical medecin department of the Limoges University Hospital;
  • Having the cognitive abilities to understand and follow simple verbal instructions (MMSE \< 24 or BDAE \< 2)
  • Be able to give informed consent to participate in this study.

Exclusion

  • Have neurological and psychiatric conditions, other than stroke;
  • Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome).
  • Inability to evolve in a virtual environment (MSSQ-Short \> 26)
  • Patient with acute cardiovascular and respiratory disorders;
  • Patient who is subject to a legal protection measure or who is unable to give consent;
  • Person deprived of liberty
  • Person with high VR experience during the 5 years before stroke
  • pregnant woman, breastfeeding woman

Key Trial Info

Start Date :

November 20 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 11 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06053619

Start Date

November 20 2023

End Date

September 11 2025

Last Update

January 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Limoges

Limoges, France, 87042